Skylight Health Group Inc. (SHG-X)
CVE:SHG
6.80
0.38
(5.92%) 1d
Financials
Technical Analysis
Related posts
Nervous markets await Nvidia- «
- ‹
- 1
- ›
- »
Skylight Health Group Inc.(SHG-X) Rating
Ranking : 1 out of 5
Bullish - Buy Signals / Votes : 0
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 0
Total Signals / Votes : 0
Skylight Health Group Inc.(SHG-X) Frequently Asked Questions
What is Skylight Health Group Inc. stock symbol?
Skylight Health Group Inc. is a Canadian stock, trading under the symbol SHG-X on the TSX Venture Exchange (SHG-CV). It is usually referred to as TSXV:SHG or SHG-X
Is Skylight Health Group Inc. a buy or a sell?
In the last year, there was no coverage of Skylight Health Group Inc. published on Stockchase.
Is Skylight Health Group Inc. a good investment or a top pick?
Skylight Health Group Inc. was recommended as a Top Pick by on . Read the latest stock experts ratings for Skylight Health Group Inc..
Why is Skylight Health Group Inc. stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Skylight Health Group Inc. worth watching?
In the last year, there was no coverage of Skylight Health Group Inc. published on Stockchase.
What is Skylight Health Group Inc. stock price?
On 2021-06-04, Skylight Health Group Inc. (SHG-X) stock closed at a price of $6.8.
They operate a multi-state U.S. health network. They're building out brick and mortrar with telehealth and speciality services there. Customers typically go in for services, but insurance companies are looking at a membership model so customers pay a fee and get access to a full suite of products. SHG is growing by acquisition and organically. Strong balance sheet and they trades at a big discount to peers. Based on their guidance for next year and their peers trading at 12-15x revenues, SHG shares should be worth $3.25 or twice current prices. He really likes management which owns a lot of shares. They're planning a Nasdaq listing. (Analysts’ price target is $1.88)